Health Care
Zimmer Biomet’s Q2 FY2026 earnings surged 29.8% as the Paragon 28 acquisition and strong robotic and bone cement sales drove revenue growth of 4.8%.
Key risk: Intensifying Pricing Pressure
Global selling prices reduced revenue growth by 0.8% in Q2, as hospitals and health systems continue cost‑containment efforts and volume‑based discounts compress margins.
Other Health Care Equipment companies